
Leadership doesn’t always mean having the answers - it means creating the conditions for others to succeed

The two companies will withdraw patent infringement proceedings filed with the US and Japan

Funds will help to push a number of pipeline candidates

The new haemophilia drug does not infringe Baxalta’s patent, rules Tokyo court

Emicizumab from Japanese affiliate Chugai cleared a phase III trial
New approvals and filings include drugs from Takeda, Otsuka, Chugai and Astellas